Sabra Health Care REIT, Inc.
Close on Oct 19, 2026
- Market cap
- $4.81B
- P/E (TTM)
- 73.4
- Dividend yield
- 6.29%
Earnings
Next report expected Nov 4, 2026, during market hours (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 3, 2026 | During market hours | – | – | – |
| Q1 FY2026 Ended Mar 31, 2026 | Apr 29, 2026 | During market hours | $221.75M | $0.16 | – |
| Q4 FY2025 Ended Dec 31, 2025 | Feb 12, 2026 | During market hours | $211.90M | $0.11 | $0.36 |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 5, 2025 | During market hours | $190.04M | $0.09 | $0.36 |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 4, 2025 | During market hours | $189.15M | $0.27 | $0.37 |
| Q1 FY2025 Ended Mar 31, 2025 | May 5, 2025 | During market hours | $183.54M | $0.17 | $0.35 |
| Q4 FY2024 Ended Dec 31, 2024 | Feb 19, 2025 | During market hours | $182.35M | $0.19 | $0.35 |
| Q3 FY2024 Ended Sep 30, 2024 | Oct 31, 2024 | During market hours | $178.00M | $0.13 | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 7, 2024 | During market hours | $176.14M | $0.10 | $0.35 |
| Q1 FY2024 Ended Mar 31, 2024 | May 8, 2024 | During market hours | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Feb 27, 2024 | During market hours | – | – | – |
Company guidance
Outlook given with results on Feb 12, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Normalized FFOnon-GAAP | 2026 | $1.49 to $1.53 | New |
| Net IncomeGAAP | 2026 | $0.60 to $0.64 | New |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Sabra Health Care REIT filed with the SEC
SABRA REPORTS SECOND QUARTER 2026 RESULTS; REITERATES 2026 GUIDANCE
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Reconciliations of Non-GAAP Financial Measures
Results of operations · Regulation FD disclosure · EX-99.3 to Form 8-K
Sabra Issues Business Update and Increases Full-Year 2026 Guidance
Regulation FD disclosure · EX-99.1 to Form 8-K
Strategic. Disciplined. Opportunistic. Investor Presentation | May 28, 2026
Regulation FD disclosure · EX-99.1 to Form 8-K
SABRA REPORTS FIRST QUARTER 2026 RESULTS; REITERATES 2026 GUIDANCE
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Reconciliations of Non-GAAP Financial Measures
Results of operations · Regulation FD disclosure · EX-99.3 to Form 8-K
SABRA REPORTS FOURTH QUARTER 2025 RESULTS; INTRODUCES 2026 GUIDANCE
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
SABRA HEALTH CARE REIT, INC.
Results of operations · Regulation FD disclosure · EX-99.3 to Form 8-K
Sabra Health Care REIT, Inc. Appoints Darrin Smith as Chief Investment Officer and Congratulates Talya Nevo-Hacohen on her Retirement
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
SABRA REPORTS THIRD QUARTER 2025 RESULTS; UPDATES 2025 GUIDANCE
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
SABRA HEALTH CARE REIT, INC.
Results of operations · Regulation FD disclosure · EX-99.3 to Form 8-K
SABRA REPORTS SECOND QUARTER 2025 RESULTS; UPDATES 2025 GUIDANCE
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
SABRA HEALTH CARE REIT, INC.
Results of operations · Regulation FD disclosure · EX-99.3 to Form 8-K
SABRA REPORTS FIRST QUARTER 2025 RESULTS; REITERATES 2025 GUIDANCE
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
SABRA HEALTH CARE REIT, INC.
Results of operations · Regulation FD disclosure · EX-99.3 to Form 8-K
Sabra Health Care REIT, Inc. Announces Chief Investment Officer Transition
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
SABRA REPORTS FOURTH QUARTER 2024 RESULTS; INTRODUCES 2025 GUIDANCE
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
SABRA HEALTH CARE REIT, INC.
Results of operations · Regulation FD disclosure · EX-99.3 to Form 8-K
SABRA REPORTS THIRD QUARTER 2024 RESULTS; UPDATES 2024 GUIDANCE
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
SABRA HEALTH CARE REIT, INC.
Results of operations · Regulation FD disclosure · EX-99.3 to Form 8-K
SABRA REPORTS SECOND QUARTER 2024 RESULTS; INCREASES 2024 GUIDANCE
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
SABRA HEALTH CARE REIT, INC.
Results of operations · Regulation FD disclosure · EX-99.3 to Form 8-K
SABRA REPORTS FIRST QUARTER 2024 RESULTS; REITERATES 2024 GUIDANCE
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
SABRA HEALTH CARE REIT, INC.
Results of operations · Regulation FD disclosure · EX-99.3 to Form 8-K
SABRA REPORTS FOURTH QUARTER 2023 RESULTS; INTRODUCES 2024 GUIDANCE
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
SABRA HEALTH CARE REIT, INC.
Results of operations · Regulation FD disclosure · EX-99.3 to Form 8-K
Sabra Health Care REIT Appoints Jessica Flores as Chief Accounting Officer
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
SABRA REPORTS THIRD QUARTER 2023 RESULTS
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.2 to Form 8-K
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K